Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal Dexamethasone for Prevention of Neonatal ARDS
NCT06188195Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of dexamethasone in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Incidence of Neonatal Acute Respiratory Distress Syndrome at 1 year, Severity of Neonatal Acute Respiratory Distress Syndrome at 1 year and 5 more. Started Feb 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06188195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188195.